Updated guidelines for management of community-acquired urinary tract infections in adult men by the French infectious disease society (SPILF)

These guidelines address acute community-acquired urinary tract infections (UTIs) in adult men. The following situations are not covered: pediatric UTIs, UTIs in immunocompromised patients, catheter-associated UTIs (vesical, ureteral, or nephrostomy), neurogenic bladder, nosocomial UTIs, chronic and recurrent UTIs. This update defines nosological entities, including confirmation of the existence of cystitis in men. Definitions are provided in the first chapter. Epidemiological and bacterial resistance data specific to male UTIs-previously scarce and fragmented-are presented in the second chapter. Pharmacokinetic and pharmacodynamic data for antibiotics used in male UTIs are comprehensively reviewed and summarized in the third section. Treatment recommendations for each entity are detailed in the fourth chapter. The final chapter outlines investigations to be considered after UTI in men and situations requiring urological referral. This document presents a concise text, and brief supporting arguments regarding key points have been added. Four clinical vignettes summarizing the diagnosis and management of cystitis, pyelonephritis, and epididymo-orchitis are presented at the end of this recommendation (Figs. 1, 2, 3 and 4).

Published by Infectious diseases now, 2026. The guideline itself is at the source linked here.

doi.org/10.1016/j.idnow.2026.105312